Literature DB >> 21262421

Medication beliefs predict medication adherence in older adults with multiple illnesses.

Benjamin Schüz1, Christopher Marx, Susanne Wurm, Lisa M Warner, Jochen P Ziegelmann, Ralf Schwarzer, Clemens Tesch-Römer.   

Abstract

OBJECTIVE: To examine factors preventing medication nonadherence in community-dwelling older adults with multiple illnesses (multimorbidity). Nonadherence threatens successful treatment of multimorbidity. Adherence problems can be intentional (e.g., deliberately choosing not to take medicines or to change medication dosage) or unintentional (e.g., forgetting to take medication) and might depend on a range of factors. This study focused in particular on the role of changes in beliefs about medication to explain changes in adherence.
METHODS: Longitudinal study with N = 309 individuals aged 65-85 years with two or more diseases at three measurement points over six months. Medication adherence and beliefs about medicines were assessed by questionnaire. Hierarchical weighted least squares regression analyses were used to predict individual intentional and unintentional nonadherence.
RESULTS: Changes in intentional nonadherence were predicted by changes in specific necessity beliefs (B = -.19, P<.01), after controlling for sociodemographic factors, health status and number of prescribed medicines. Changes in unintentional nonadherence were predicted by changes in general overuse beliefs (B = .26, P<.01), controlling for the same covariates.
CONCLUSION: Beliefs about medication affect both intentional and unintentional adherence to medication in multimorbid older adults. This points to the importance of addressing medication beliefs in patient education to improve adherence.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21262421     DOI: 10.1016/j.jpsychores.2010.07.014

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  32 in total

1.  [Autonomy despite multimorbidity in old age--the Berlin-based AMA research consortium].

Authors:  B Schüz; D Dräger; S Richter; K Kummer; A Kuhlmey; C Tesch-Römer
Journal:  Z Gerontol Geriatr       Date:  2011-12       Impact factor: 1.281

2.  [Management and therapy of atrial fibrillation in geriatric patients].

Authors:  M Gosch; R E Roller; B Böhmdorfer; U Benvenuti-Falger; B Iglseder; M Lechleitner; U Sommeregger; P Dovjak
Journal:  Z Gerontol Geriatr       Date:  2012-01       Impact factor: 1.281

3.  How do we better translate adherence research into improvements in patient care?

Authors:  Adam La Caze; Gina Gujral; William Neil Cottrell
Journal:  Int J Clin Pharm       Date:  2014-02

4.  Association of Medication Beliefs, Self-efficacy, and Adherence in a Diverse Cohort of Adults with Rheumatoid Arthritis.

Authors:  Caroline McCulley; Patricia Katz; Laura Trupin; Edward H Yelin; Jennifer L Barton
Journal:  J Rheumatol       Date:  2018-09-15       Impact factor: 4.666

Review 5.  Intentional non-adherence to medications by older adults.

Authors:  Omar Mukhtar; John Weinman; Stephen H D Jackson
Journal:  Drugs Aging       Date:  2014-03       Impact factor: 3.923

6.  Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2012-09-19       Impact factor: 5.562

Review 7.  Reconsideration of key articles regarding medication-related problems in older adults from 2011.

Authors:  Carolyn T Thorpe; Holly C Lassila; Christine K O'Neil; Joshua M Thorpe; Joseph T Hanlon; Robert L Maher
Journal:  Am J Geriatr Pharmacother       Date:  2012-02

Review 8.  Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review.

Authors:  M T E Puts; H A Tu; A Tourangeau; D Howell; M Fitch; E Springall; S M H Alibhai
Journal:  Ann Oncol       Date:  2013-11-26       Impact factor: 32.976

9.  Subtle Changes in Medication-taking Are Associated With Incident Mild Cognitive Impairment.

Authors:  Katherine E Dorociak; Nora Mattek; John E Ferguson; Zachary T Beattie; Nicole Sharma; Jeffrey A Kaye; Mira I Leese; Bridget M Doane; Adriana M Hughes
Journal:  Alzheimer Dis Assoc Disord       Date:  2021 Jul-Sep 01       Impact factor: 2.703

10.  The use of erlotinib in daily practice: a study on adherence and patients' experiences.

Authors:  Lonneke Timmers; Christel C L M Boons; Dirk Mangnus; Josee E Moes; Eleonora L Swart; Epie Boven; Egbert F Smit; Jacqueline G Hugtenburg
Journal:  BMC Cancer       Date:  2011-07-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.